Skip to main content
NCBI home page
Journal of the Royal Society of Medicine logoLink to Journal of the Royal Society of Medicine
. 2004;97(Suppl 44):48–51.

Vitamin K in cystic fibrosis.

S P Conway 1
PMCID: PMC1308799  PMID: 15239294

Full Text

The Full Text of this article is available as a PDF (58.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beker L. T., Ahrens R. A., Fink R. J., O'Brien M. E., Davidson K. W., Sokoll L. J., Sadowski J. A. Effect of vitamin K1 supplementation on vitamin K status in cystic fibrosis patients. J Pediatr Gastroenterol Nutr. 1997 May;24(5):512–517. doi: 10.1097/00005176-199705000-00003. [DOI] [PubMed] [Google Scholar]
  2. Borowitz Drucy, Baker Robert D., Stallings Virginia. Consensus report on nutrition for pediatric patients with cystic fibrosis. J Pediatr Gastroenterol Nutr. 2002 Sep;35(3):246–259. doi: 10.1097/00005176-200209000-00004. [DOI] [PubMed] [Google Scholar]
  3. Choonara I. A., Winn M. J., Park B. K., Littlewood J. M. Plasma vitamin K1 concentrations in cystic fibrosis. Arch Dis Child. 1989 May;64(5):732–734. doi: 10.1136/adc.64.5.732. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conly J. M., Stein K., Worobetz L., Rutledge-Harding S. The contribution of vitamin K2 (menaquinones) produced by the intestinal microflora to human nutritional requirements for vitamin K. Am J Gastroenterol. 1994 Jun;89(6):915–923. [PubMed] [Google Scholar]
  5. Cornelissen E. A., van Lieburg A. F., Motohara K., van Oostrom C. G. Vitamin K status in cystic fibrosis. Acta Paediatr. 1992 Sep;81(9):658–661. doi: 10.1111/j.1651-2227.1992.tb12327.x. [DOI] [PubMed] [Google Scholar]
  6. Corrigan J. J., Jr, Taussig L. M., Beckerman R., Wagener J. S. Factor II (prothrombin) coagulant activity in immunoreactive protein: detection of vitamin K deficiency and liver disease in patients with cystic fibrosis. J Pediatr. 1981 Aug;99(2):254–257. doi: 10.1016/s0022-3476(81)80468-4. [DOI] [PubMed] [Google Scholar]
  7. DI SANT'AGNESE P. A., VIDAURRETA A. M. Cystic fibrosis of the pancreas. J Am Med Assoc. 1960 Apr 30;172:2065–2072. doi: 10.1001/jama.1960.63020180021011e. [DOI] [PubMed] [Google Scholar]
  8. Durie P. R. Vitamin K and the management of patients with cystic fibrosis. CMAJ. 1994 Oct 1;151(7):933–936. [PMC free article] [PubMed] [Google Scholar]
  9. Ferland G., Sadowski J. A., O'Brien M. E. Dietary induced subclinical vitamin K deficiency in normal human subjects. J Clin Invest. 1993 Apr;91(4):1761–1768. doi: 10.1172/JCI116386. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Matsunaga S., Ito H., Sakou T. The effect of vitamin K and D supplementation on ovariectomy-induced bone loss. Calcif Tissue Int. 1999 Oct;65(4):285–289. doi: 10.1007/s002239900700. [DOI] [PubMed] [Google Scholar]
  11. Mosler Katharina, von Kries Rüdiger, Vermeer Cees, Saupe Jörg, Schmitz Thomas, Schuster Antje. Assessment of vitamin K deficiency in CF--how much sophistication is useful? J Cyst Fibros. 2003 Jun;2(2):91–96. doi: 10.1016/S1569-1993(03)00025-0. [DOI] [PubMed] [Google Scholar]
  12. Paiva S. A., Sepe T. E., Booth S. L., Camilo M. E., O'Brien M. E., Davidson K. W., Sadowski J. A., Russell R. M. Interaction between vitamin K nutriture and bacterial overgrowth in hypochlorhydria induced by omeprazole. Am J Clin Nutr. 1998 Sep;68(3):699–704. doi: 10.1093/ajcn/68.3.699. [DOI] [PubMed] [Google Scholar]
  13. Ramsey B. W., Farrell P. M., Pencharz P. Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee. Am J Clin Nutr. 1992 Jan;55(1):108–116. doi: 10.1093/ajcn/55.1.108. [DOI] [PubMed] [Google Scholar]
  14. Rashid M., Durie P., Andrew M., Kalnins D., Shin J., Corey M., Tullis E., Pencharz P. B. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr. 1999 Sep;70(3):378–382. doi: 10.1093/ajcn/70.3.378. [DOI] [PubMed] [Google Scholar]
  15. SHWACHMAN H. Therapy of cystic fibrosis of the pancreas. Pediatrics. 1960 Jan;25:155–163. [PubMed] [Google Scholar]
  16. Saupe J., Shearer M. J., Kohlmeier M. Phylloquinone transport and its influence on gamma-carboxyglutamate residues of osteocalcin in patients on maintenance hemodialysis. Am J Clin Nutr. 1993 Aug;58(2):204–208. doi: 10.1093/ajcn/58.2.204. [DOI] [PubMed] [Google Scholar]
  17. Shearer M. J. Vitamin K. Lancet. 1995 Jan 28;345(8944):229–234. doi: 10.1016/s0140-6736(95)90227-9. [DOI] [PubMed] [Google Scholar]
  18. Sinaasappel M., Stern M., Littlewood J., Wolfe S., Steinkamp G., Heijerman Harry G. M., Robberecht E., Döring G. Nutrition in patients with cystic fibrosis: a European Consensus. J Cyst Fibros. 2002 Jun;1(2):51–75. doi: 10.1016/s1569-1993(02)00032-2. [DOI] [PubMed] [Google Scholar]
  19. Sokol R. J., Reardon M. C., Accurso F. J., Stall C., Narkewicz M., Abman S. H., Hammond K. B. Fat-soluble-vitamin status during the first year of life in infants with cystic fibrosis identified by screening of newborns. Am J Clin Nutr. 1989 Nov;50(5):1064–1071. doi: 10.1093/ajcn/50.5.1064. [DOI] [PubMed] [Google Scholar]
  20. Sokoll L. J., Booth S. L., O'Brien M. E., Davidson K. W., Tsaioun K. I., Sadowski J. A. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr. 1997 Mar;65(3):779–784. doi: 10.1093/ajcn/65.3.779. [DOI] [PubMed] [Google Scholar]
  21. Torstenson O. L., Humphrey G. B., Edson J. R., Warwick W. J. Cystic fibrosis presenting with severe hemorrhage due to vitamin K malabsorption: a report of three cases. Pediatrics. 1970 May;45(5):857–861. [PubMed] [Google Scholar]
  22. Verghese T., Beverley D. Vitamin K deficient bleeding in cystic fibrosis. Arch Dis Child. 2003 Jun;88(6):553–553. doi: 10.1136/adc.88.6.553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Vermeer C., Jie K. S., Knapen M. H. Role of vitamin K in bone metabolism. Annu Rev Nutr. 1995;15:1–22. doi: 10.1146/annurev.nu.15.070195.000245. [DOI] [PubMed] [Google Scholar]
  24. Vermeer C., Knapen M. H., Schurgers L. J. Vitamin K and metabolic bone disease. J Clin Pathol. 1998 Jun;51(6):424–426. doi: 10.1136/jcp.51.6.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Walters T. R., Koch H. F. Hemorrhagic diathesis and cystic fibrosis in infancy. Am J Dis Child. 1972 Nov;124(5):641–642. doi: 10.1001/archpedi.1972.02110170019002. [DOI] [PubMed] [Google Scholar]
  26. Weber P. Vitamin K and bone health. Nutrition. 2001 Oct;17(10):880–887. doi: 10.1016/s0899-9007(01)00709-2. [DOI] [PubMed] [Google Scholar]
  27. Wilson D. C., Rashid M., Durie P. R., Tsang A., Kalnins D., Andrew M., Corey M., Shin J., Tullis E., Pencharz P. B. Treatment of vitamin K deficiency in cystic fibrosis: Effectiveness of a daily fat-soluble vitamin combination. J Pediatr. 2001 Jun;138(6):851–855. doi: 10.1067/mpd.2001.113633. [DOI] [PubMed] [Google Scholar]
  28. de Montalembert M., Lenoir G., Saint-Raymond A., Rey J., Lefrère J. J. Increased PIVKA-II concentrations in patients with cystic fibrosis. J Clin Pathol. 1992 Feb;45(2):180–181. doi: 10.1136/jcp.45.2.180. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES